Download presentation
Presentation is loading. Please wait.
Published byAnnabel Angelina Cannon Modified over 7 years ago
1
Alterations of Leukocyte, Lymphoid, and Hemostatic Function
Chapter 27 Alterations of Leukocyte, Lymphoid, and Hemostatic Function Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
2
Alterations of Leukocyte Function
Deficiencies in the quality and quantity of leukocytes (leukopenia) Increased numbers of leukocytes (leukocytosis) Many hematologic disorders are malignancies Many nonhematologic malignancies metastasize to bone marrow, affecting leukocyte production
4
Alterations of Leukocyte Function
Quantitative disorders Increases or decreases in cell numbers Bone marrow disorders or premature destruction of cells Response to infectious microorganism invasion Qualitative disorders Disruption of cellular function
5
Quantitative Alterations of Leukocytes
Leukocytosis Counts higher than normal Leukocytosis is a normal protective physiologic response to stressors Leukopenia Counts lower than normal Leukopenia is always abnormal Low WBC count predisposes to infections
8
Granulocytosis (Neutrophilia)
Evident in first stages of infection/inflammation If need for neutrophils increases beyond the supply, immature neutrophils (banded neutrophils) released into the blood Premature release detected in manual WBC differential and is termed a shift to the left Leukemoid reaction When the population returns to normal, it is termed a shift to the right
9
Neutropenia Reduction in circulating neutrophils Primary Secondary
Congenital Cyclic neutropenia and neutropenia with congenital immunodeficiency diseases Multiple syndromes Acquired Multiple conditions (hypoplastic anemia, aplastic anemia, leukemias, lymphomas [Hodgkin, non-Hodgkin]; myelodysplastic syndrome) Secondary
10
Neutropenia Causes Prolonged severe infection Decreased production
Reduced survival Abnormal neutrophil distribution and sequestration
11
Granulocytopenia (Agranulocytosis)
Causes Interference with hematopoiesis Immune mechanisms Chemotherapy destruction Ionizing radiation Sepsis caused by agranulocytosis often results in death within 3 to 6 days
12
Eosinophilia Hypersensitivity reactions trigger the release of eosinophilic chemotactic factor of anaphylaxis from mast cells Increased in allergic disorders Increased in parasitic invasions
13
Eosinopenia Decrease in circulation numbers of eosinophils
Usually caused by migration of cells to inflammatory sites Other causes Surgery, shock, trauma, burns, or mental distress
14
Basophils Basophils account for only up to 1% of the circulating WBCs
Basophilia Response to inflammation and hypersensitivity reactions Basopenia Occurs in acute infections, hyperthyroidism, and long-term steroid therapy
15
Monocytes Monocytosis Monocytopenia Poor correlation with disease
Usually occurs with neutropenia in later stages of infections Monocytes are needed to phagocytize organisms and debris Monocytopenia Very little known about this condition Prednisone treatments Hairy cell leukemia
16
Lymphocytes Lymphocytosis Lymphocytopenia Acute viral infections
Epstein-Barr virus Lymphocytopenia Immune deficiencies, drug destruction, viral destruction
17
Infectious Mononucleosis (IM)
Acute, self-limiting infection of B lymphocytes transmitted by saliva through personal contact Commonly caused by the Epstein-Barr virus (EBV)—85% B cells have an EBV receptor site Others viral agents resembling IM Cytomegalovirus (CMV), hepatitis, influenza, HIV
18
Infectious Mononucleosis
Symptoms: fever, sore throat, swollen cervical lymph nodes, increased lymphocyte count, and atypical (activated) lymphocytes; may affect multiple systems Serious complications are infrequent (<5%) Splenic rupture is the most common cause of death Lab values: >50% lymphocytes and at least 10% atypical lymphocytes Diagnostic test Monospot qualitative test for heterophilic antibodies Treatment: symptomatic
20
Infectious Mononucleosis - 1.
Large irregular atypical lymphocytes seen in the peripheral blood of a patient with infectious mononucleosis. The indentation of the cytoplasm of the lymphocyte (arrows) by red blood cells gives rise to the classic "Dutch skirt" appearance of the border.
22
Leukemias Malignant disorder of the blood and blood-forming organs
Uncontrolled proliferation of malignant leukocytes Overcrowding of bone marrow Decreased production and function of normal hematopoietic cells
23
Leukemias Acute leukemia Chronic leukemia
Presence of undifferentiated or immature cells, usually blast cells Rapid onset with short survival Chronic leukemia Predominant cell is mature but does not function normally Slow progression
24
Leukemias Acute lymphocytic leukemia (ALL)
Least common overall but most common childhood leukemia (80%) Acute myelogenous leukemia (AML) Most common adult leukemia (mean age, 67)
26
A, Lymphoblasts show significant vacuolation and basophilic cytoplasm
A, Lymphoblasts show significant vacuolation and basophilic cytoplasm. B, Myeloperoxidase stain shows positive staining in most lymphoblasts
27
Leukemias Chronic myelogenous leukemia (CML)
Usually diagnosed in adults Chronic lymphocytic leukemia (CLL) Common in adults (70% asymptomatic at diagnosis) Lymphadenopathy Suppression of humoral immunity Increased infection with encapsulated bacteria
28
Leukemias Signs and symptoms of leukemias
Anemia, bleeding purpura, petechiae, ecchymosis, thrombosis, hemorrhage, DIC, infection, weight loss, bone pain, elevated uric acid, and liver, spleen, and lymph node enlargement Clonal disorder in that a single progenitor cell undergoes malignant transformation
29
Lymphadenopathy Enlarged lymph nodes that become palpable and tender
Local lymphadenopathy Drainage of an inflammatory lesion located near the enlarged node General lymphadenopathy Occurs in the presence of malignant or nonmalignant disease
30
Lymphadenopathy Causes Neoplastic disease
Immunologic or inflammatory conditions Endocrine disorders Lipid storage diseases
31
Lymphadenopathy
32
Malignant Lymphomas Malignant transformation of a lymphocyte and proliferation of lymphocytes, histiocytes, their precursors, and derivatives in lymphoid tissues Two major categories Hodgkin lymphoma Linked to EBV Non-Hodgkin lymphoma Lymphoblastic lymphoma
33
Hodgkin Lymphoma Reed-Sternberg cells in the lymph nodes
These cells necessary for diagnosis, but not specific to Hodgkin lymphoma Classical Hodgkin lymphoma Nodular lymphocyte predominant Hodgkin lymphoma B cell in the germinal center that has not undergone successful immunoglobulin gene rearrangement but has undergone apoptosis
34
Hodgkin Lymphoma Physical findings Symptoms Laboratory findings
Adenopathy, mediastinal mass, splenomegaly, and abdominal mass Symptoms Fever, weight loss, night sweats, pruritus Laboratory findings Thrombocytosis, leukocytosis, eosinophilia, elevated erythrocyte sedimentation rate (ESR), elevated alkaline phosphatase Paraneoplastic syndromes
35
Hodgkin Lymphoma
36
Hodgkin Lymphoma
37
Non-Hodgkin Lymphoma Generic term for diverse group of lymphomas
The lymphomas can be differentiated based on etiology, unique features, and response to therapies Non-Hodgkin lymphomas are linked to chromosome translocations, viral and bacterial infections, environmental agents, immunodeficiencies, and autoimmune disorders
38
Non-Hodgkin Lymphoma Clonal expansion of B cells (85%), T cells, and/or NK cells Changes in proto-oncogenes and tumor-suppressor genes contribute to cell immortality and thus an increase in malignant cells
39
Burkitt Lymphoma Most common type of non-Hodgkin lymphoma in children
A very fast-growing tumor of the jaw and facial bones Epstein-Barr virus is found in nasopharyngeal secretions of individuals
40
Burkitt Lymphoma
41
Plasma Cell Malignancies
Multiple Myeloma Waldenström
42
Multiple Myeloma Proliferation of plasma cells
The tumor may be solitary or multifocal (multiple myeloma) The malignant plasma cells produce abnormally large amounts of one class of immunoglobulin or incomplete immunoglobulin The unattached light chains of the immunoglobulins (Bence Jones proteins) can pass through the glomerulus and damage the renal tubular cells
43
Multiple Myeloma Increased osteoclastic bone destruction
Hypercalcemia (13%), renal failure (19%), anemia (72%), bone lesions (80%) Clinical manifestations Cortical and medullary bone loss Skeletal pain Recurring infections due to loss of the humoral immune response
44
Alterations in Splenic Function
Splenomegaly Hypersplenism Congestive splenomegaly Infiltrative splenomegaly Removal of the spleen Increased WBCs and platelets RBC abnormalities
45
Disorders of Platelets
Thrombocytopenia Platelet count <100,000/mm3 <50,000/mm3—hemorrhage from minor trauma <15,000/mm3—spontaneous bleeding <10,000/mm3—severe bleeding Causes: Hypersplenism, autoimmune disease, hypothermia, and viral or bacterial infections that cause DIC
46
Disorders of Platelets
Immune thrombocytopenic purpura (ITP) IgG antibody targets platelet glycoproteins Antibody-coated platelets are sequestered and removed from the circulation Acute form develops after viral infections One of the most common childhood bleeding disorders Manifestations Petechiae and purpura, progressing to major hemorrhage
47
Disorders of Platelets
Thrombotic thrombocytopenic purpura (TTP) A thrombotic microangiopathy Platelets aggregate, form microthrombi, and cause occlusion of arterioles and capillaries Chronic relapsing TTP Acute idiopathic TTP
48
Disorders of Platelets
Essential (primary) thrombocythemia Thrombocythemia is characterized by platelet counts >600,000/mm3 Myeloproliferative disorder of platelet precursor cells Megakaryocytes in the bone marrow are produced in excess Microvasculature thrombosis occurs
49
Alterations of Platelet Function
Qualitative alterations demonstrate an increased bleeding time in the presence of a normal platelet count Disorders result from platelet membrane glycoprotein and von Willebrand factor deficiencies Manifestations Petechiae, purpura, mucosal bleeding, gingival bleeding, and spontaneous bruising Disorders can be congenital or acquired
50
Alterations of Coagulation
Vitamin K deficiency Vitamin K is necessary for synthesis and regulation of prothrombin, the prothrombin factors (II, VII, XI, X), and proteins C and S (anticoagulants) Liver disease Causes broad range of hemostasis disorders Defects in coagulation, fibrinolysis, and platelet number and function
51
Disseminated Intravascular Coagulation (DIC)
Complex, acquired disorder: clotting and hemorrhage simultaneously occur Sepsis, cancer, trauma, blood transfusion Result of increased protease activity in the blood caused by unregulated release of thrombin with subsequent fibrin formation and accelerated fibrinolysis Endothelial damage is primary initiator
52
Disseminated Intravascular Coagulation (DIC)
Blockage of blood flow to organs, resulting in multiple organ failure Magnitude of clotting may result in consumption of platelets and clotting factors, leading to severe bleeding
53
Disseminated Intravascular Coagulation (DIC)
The amount of activated thrombin exceeds the body’s antithrombins and the thrombin does not remain localized The widespread thromboses created cause widespread ischemia, infarction, and organ hypoperfusion
54
Disseminated Intravascular Coagulation (DIC)
By activating the fibrinolytic system (plasmin), person’s fibrin degradation product and D-dimer levels increase Due to the person’s clinical state, the disorder has a high mortality rate Treatment is to remove the stimulus
55
Disseminated Intravascular Coagulation (DIC)
Clinical signs and symptoms demonstrate wide variability Bleeding from venipuncture sites Bleeding from arterial lines Purpura, petechiae, and hematomas Symmetric cyanosis of the fingers and toes
56
Thromboembolic Disease
Arterial thrombi Defects in proteins involved in hemostasis Venous thrombi Variety of clinical disorders or conditions Hypercoagulabilty (thrombophilia) Acquired Mutations in coagulation proteins, fibrinolytic proteins, platelet receptors Triad of Virchow
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.